ArticleNeoplasia (New York, N.Y.)2022

Targeting GRP78 suppresses oncogenic KRAS protein expression and reduces viability of cancer cells bearing various KRAS mutations.

Dat P Ha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.